Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
quality control
Manufacturing
FDA hits Piramal with 6-observation Form 483 at India API plant
Roughly a year after receiving an FDA reprimand at its plant in Michigan, Piramal Pharma has landed in the regulator’s crosshairs once again.
Fraiser Kansteiner
Feb 26, 2025 10:22am
Sanofi hit with warning letter at Massachusetts ingredient plant
Jan 21, 2025 12:26pm
FDA warning letter reveals production errors at Viatris plant
Jan 6, 2025 4:20pm
Novo unveils plans for $400M quality control hub in Denmark
Dec 4, 2024 2:53pm
MilliporeSigma plugs €62M into new quality control building
Jun 14, 2024 10:00am
China's Hengrui hit with Form 483 for manufacturing shortfalls
Jun 6, 2024 9:29am
